Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
JCO Precision Oncology|March 14, 2024
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With RuxolitinibAndrew T Kuykendall, Somedeb Ball, Barbara Mora, et al.
Antioxidants (Basel, Switzerland)|August 26, 2022
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo ModelsGiuseppe Carota, Alfio Distefano, Mariarita Spampinato, et al.
Antioxidants (Basel, Switzerland)|December 23, 2023
Correction: Carota et al. Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models. Antioxidants 2022, 11, 1596Giuseppe Carota, Alfio Distefano, Mariarita Spampinato, et al.
Cancer|September 2, 2023
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditionsAndrea Duminuco, Antonella Nardo, Alessandra Orofino, et al.
Discover Oncology|March 11, 2026
Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironmentEnrico La Spina, Cesarina Giallongo, Lucia Longhitano, et al.
Clinical Case Reports|July 20, 2023
A case of high-risk AML in a patient with advanced systemic mastocytosisManlio Fazio, Calogero Vetro, Uroš Markovic, et al.
International Journal of Hematology|June 27, 2020
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severityGiovanni Caocci, Marco Vignetti, Andrea Patriarca, et al.
Cell Proliferation|February 16, 2023
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myelomaAlessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Redox Biology|September 1, 2020
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomibGiuseppina Camiolo, Alessandro Barbato, Cesarina Giallongo, et al.
Leukemia & Lymphoma|June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomideRossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Pageof 12